Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.
Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.
AdaptHealth Corp. (NASDAQ: AHCO) reported second-quarter financial results for 2022, highlighting a net revenue of $727.6 million, a 17.9% increase from $617.0 million in 2021. Adjusted EBITDA rose 1.8% to $150.0 million, with an EBITDA margin improvement to 20.6%. However, net income dropped to $14.0 million from $79.1 million year-over-year. Non-acquired net revenue slightly decreased by 0.3%. The company maintained its 2022 guidance, projecting net revenue between $2.840 billion and $3.040 billion.
AdaptHealth Corp. (NASD: AHCO) will be added to the S&P SmallCap 600 index, effective August 4, 2022. This change comes as Cummins Inc. (NYSE: CMI) is acquiring Meritor Inc. (NYSE: MTOR), which is being removed from the index. The transition reflects a strategic reshuffle in the S&P indices as AdaptHealth enhances its presence in the health care sector. The acquisition of Meritor by Cummins is expected to complete soon, pending closing conditions.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q2 2022 financial results before market open on August 9, 2022. A teleconference hosted by management is scheduled for 8:30 a.m. ET to discuss the results and future business activities. Participants can join by calling (877) 407-6176 for domestic or (201) 689-8451 for international calls. A replay will be available for six months on the company's website under 'Investor Relations'. AdaptHealth offers patient-centered healthcare-at-home solutions, serving 3.9 million patients yearly across 50 states.
AdaptHealth Corp. (NASDAQ: AHCO) has announced that Josh Parnes, President, and Jason Clemens, CFO, will participate in a fireside chat at the Jefferies Healthcare Conference on June 8 at 10:00 am ET. A live webcast will be available on AdaptHealth's website for those interested in attending.
AdaptHealth is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the United States.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the UBS Global Healthcare Conference on May 25, 2022, at 10:00 am ET. President Josh Parnes and CFO Jason Clemens will represent the Company, a leader in patient-centered healthcare-at-home solutions. Interested parties can access a live webcast on AdaptHealth's website. The Company serves around 3.9 million patients annually through over 750 locations nationwide, offering medical equipment and services designed for chronic condition management.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the RBC Capital Markets 2022 Global Healthcare Conference on May 17, 2022, at 10:30 am ET. President Josh Parnes and CFO Jason Clemens will represent the company. A live webcast will be available on AdaptHealth’s website, which should be accessed 5-10 minutes before the session. AdaptHealth is a leader in patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced strong financial results for Q1 2022, with net revenue of $706.2 million, a 46.5% increase from the previous year. Adjusted EBITDA rose 32.1% to $137.6 million. The company reported a net income of $41.8 million compared to a net loss of $4.0 million in Q1 2021. A share repurchase program for up to $200 million was authorized, reflecting confidence in the company's outlook. AdaptHealth has continued to address challenges from CPAP equipment shortages and has completed six acquisitions this year, with updated revenue guidance for 2022 between $2.840 billion and $3.040 billion.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11 at 12:40 pm PT. CEO Steve Griggs and CFO Jason Clemens will lead the discussion, which can be accessed via a live webcast on AdaptHealth's website. The company is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.8 million patients annually across the U.S. through over 750 locations. This includes services for chronic conditions like sleep apnea and diabetes.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q1 2022 financial results on May 10, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for discussions regarding the results and business activities. This company is a leader in patient-centered healthcare-at-home solutions, offering products like sleep therapy equipment, diabetes supplies, and oxygen services through a network covering approximately 3.8 million patients in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported exceptional results for 2021, with revenues soaring to $2.45 billion, more than double the $1.06 billion from 2020. The company serves around 3.8 million patients annually, despite facing challenges from CPAP shortages. The fourth quarter revenue reached a record $702.1 million, marking a 102% increase year-over-year. Net income for the quarter was $22.9 million, a significant recovery from a net loss of $80.5 million in Q4 2020. AdaptHealth updated its 2022 guidance, expecting revenues between $2.825 billion and $3.025 billion.